Celldex Therapeutics (CLDX) Misses Q1 Views on Top and Bottom

May 2, 2013 8:48 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q1 EPS of ($0.20), $0.02 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found